№ files_lp_3_process_7_015511
File format: docx
Character count: 73111
File size: 246 KB
Supplementary scientific material presenting figures and tables with epidemiological time series, genome sequencing data, phylogenetic analyses, and GISAID acknowledgments related to SARS-CoV-2 cases and viral genomes from Guangdong and other regions up to 19 March 2020.
Year:
2020
Region:
Guangdong Province, China
Topic:
Genomic epidemiology of SARS-CoV-2
Document type:
Supplementary information to a scientific research article
Associated article:
Genomic epidemiology of SARS-CoV-2 in Guangdong Province, China
Authors:
Jing Lu; Louis du Plessis; Zhe Liu; Verity Hill; Min Kang; Huifang Lin; Jiufeng Sun; Sarah François; Moritz U G Kraemer; Nuno R Faria; John T McCrone; Jingju Peng; Qianlin Xiong; Runyu Yuan; Lilian Zeng; Pingping Zhou; Chuming Liang; Lina Yi; Jun Liu; Jianpeng Xiao; Jianxiong Hu; Tao Liu; Wenjun Ma; Wei Li; Juan Su; Huanying Zheng; Bo Peng; Shisong Fang; Wenzhe Su; Kuibiao Li; Ruilin Sun; Ru Bai; Xi Tang; Minfeng Liang; Josh Quick; Tie Song; Andrew Rambaut; Nick Loman; Jayna Raghwani; Oliver G Pybus; Changwen Ke
Affiliated institutions:
Guangdong Provincial Center for Disease Control and Prevention; University of Oxford; University of Edinburgh; Shenzhen Center for Disease Control and Prevention; Guangzhou Center for Disease Control and Prevention; Guangdong Provincial Second People’s Hospital; Foshan First People’s Hospital; University of Birmingham
Data coverage period:
Up to 19 March 2020
Number of reported genomes:
53 newly reported SARS-CoV-2 genomes
Total cases referenced:
1388 laboratory-confirmed COVID-19 cases
Figures:
S1–S4
Tables:
S1–S2
Data sources:
RT-PCR testing; whole-genome sequencing; GISAID database
Geographic scope of comparative data:
Guangdong; Hubei; USA (California, Wisconsin); Japan; Singapore; Jiangsu; Fujian; India; Vietnam
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.
The file will be delivered to the email address provided at checkout within 12 hours.
Don’t have cryptocurrency yet?
You can still complete your purchase in a few minutes:- Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
- In the app, tap Send.
- Select network, paste our wallet address.
- Send the exact amount shown above.
The final amount may vary slightly depending on the payment method.
The file will be sent to the email address provided at checkout within 24 hours.
The product description is provided for reference. Actual content and formatting may differ slightly.
Note:
Year
Topic:
Social Security
Document Type:
Pamphlet
Agency / Organization:
Social Welfare Department (SWD)
Target Audience:
Hong Kong residents aged 65 and above
Year:
2019
Country:
China
Region / City:
Guangdong Province; Guangzhou
Field:
Virology; Infectious Diseases; Molecular Epidemiology
Document Type:
Supplementary scientific data tables
Journal:
Virologica Sinica
Institutions:
State Key Laboratory of Respiratory Diseases; National Clinical Research Center for Respiratory Disease; Guangzhou Medical University; The First Affiliated Hospital of Guangdong Pharmaceutical University; Bioland Laboratory; Guangzhou Laboratory
Authors:
Wenkuan Liu; Shuyan Qiu; Li Zhang; Hongkai Wu; Xingui Tian; Xiao Li; Duo Xu; Jing Dai; Shujun Gu; Qian Liu; Dehui Chen; Rong Zhou
Corresponding Authors:
Rong Zhou; Dehui Chen; Qian Liu
Subject:
Human adenovirus infection outbreak and genomic analysis
Data Types:
PCR primers and probes; gene primer sequences; comparative genomics mutations
Virus Types Covered:
HAdV21; HAdV3; HAdV7; HAdV14; HAdV55; HAdV5; HAdV4
Genes Analyzed:
Hexon; Penton base; Fiber
Reference Genome:
HAdV-7 strain CQ1198 (accession no. JX625134)
Geographic Focus of Study:
Guangdong Province, Southern China
Year:
2026
Region / City:
Guangdong, Fujian, Hong Kong
Theme:
Social Welfare, Elderly Support
Document Type:
Informational Pamphlet
Organization:
Social Welfare Department (SWD), Hong Kong
Author:
Social Welfare Department
Target Audience:
Elderly Hong Kong residents residing in Guangdong or Fujian
Effective Period:
Ongoing
Approval Date:
Not specified
Date of Changes:
Not specified
Year:
2020
Region / city:
Global
Theme:
COVID-19 Pandemic, Health Risk Assessment
Document type:
Report
Organization:
Centers for Disease Control and Prevention (CDC), World Health Organization (WHO)
Author:
Centers for Disease Control and Prevention (CDC)
Target audience:
Public health officials, healthcare providers, researchers
Validity period:
Ongoing
Approval date:
October 19, 2020
Date of changes:
Ongoing
Year:
2020
Region / City:
New South Wales, Australia
Topic:
Biology, SARS-CoV-2, RNA, Vaccination, Infectious Diseases
Document Type:
Educational Resource
Organization / Institution:
New South Wales Education Standards Authority (NESA)
Author:
Not specified
Target Audience:
Year 12 students
Period of Validity:
2020 and onwards
Approval Date:
2017
Date of Changes:
Not specified
Year:
2021
Region / city:
United States
Topic:
COVID-19, occupational health, risk assessment
Document type:
Report
Organization / institution:
CSTE Occupational Health Subcommittee
Author:
CSTE Occupational Health Subcommittee, Work Group on Essential Workers - Exposure Measures Team
Target audience:
Epidemiologists, policymakers, occupational health experts
Effective period:
From August 18, 2021
Approval date:
August 18, 2021
Date of changes:
August 18, 2021
Year:
2021
Region / city:
Various locations in the United States
Topic:
COVID-19 Treatment
Document type:
Clinical Trial Report
Institution:
Regeneron Pharmaceuticals, NIAID/CoVPN
Author:
Multiple investigators and research teams
Target audience:
Healthcare professionals, researchers, clinical trial coordinators
Period of validity:
Study conducted during 2020-2021
Approval date:
Not specified
Date of changes:
Not specified
Document Type:
Supplementary data appendix
Subject:
Development and validation of a rapid viability RT-PCR (RV-RT-PCR) method for detection of infectious SARS-CoV-2
Pathogen:
SARS-CoV-2
Experimental Model:
Vero E6 cells
Institutions:
U.S. Environmental Protection Agency, Office of Research and Development; Lawrence Livermore National Laboratory
Authors:
Sanjiv R. Shah; Staci R. Kane; Maher Elsheikh; Teneile M. Alfaro
Geographic Location:
Washington, District of Columbia, USA; Livermore, California, USA
Data Type:
RT-PCR cycle threshold (CT) measurements; plaque forming units (PFU); TCID50 values; recovery efficiency data
Infection Conditions:
1-hour and 2-hour infection periods with post-infection incubation at T0, T12, and T24
Sample Type:
SARS-CoV-2-infected cell cultures and swab swatches
Analytical Replicates:
Triplicate RT-PCR analyses with pooled standard deviations
Tables Included:
Table S1; Table S2; Table S3; Table S4
Year:
2022
Region / City:
N/A
Subject:
Molecular interaction studies
Document Type:
Supplementary data
Organization / Institution:
N/A
Author:
N/A
Target Audience:
Researchers in biochemistry, molecular biology, and virology
Period of Validity:
N/A
Approval Date:
N/A
Modification Date:
N/A
Year:
2021
Study type:
Clinical research
Document type:
Supplementary materials
Authors:
Not specified
Institution:
Not specified
Target audience:
Researchers in oncology and virology
Tumor types:
Glioma, Meningioma, Pituitary adenoma, Craniopharyngioma, Ependymoma, Schwannoma, Haemangioblastoma, Chordoma, Brain metastases from breast, lung, kidney, colon cancer
Methods:
Immunohistochemistry, Immunofluorescence, Gene expression analysis, KEGG enrichment, GSEA
Patient information:
Age, Sex, Preexisting conditions, Preoperative treatment, SARS-CoV-2 PCR status
Figures included:
S1–S6
Tables included:
S1
Key markers analyzed:
ACE2, TMPRSS2, CD147, NRP1, IFN-γ, PD-1, FOXP3, CD8, CD4, C1q, C3, IgG, IgM, CD68, TTF1, MUC1
Year:
2026
Region / Institution:
Not specified
Topic:
Immunology, SARS-CoV-2, Vaccine Response
Document type:
Peer Review
Author:
Stefania P Bjarnarson
Target audience:
Researchers, Immunologists
Study period:
Up to 33 months post mRNA vaccination
Methods:
Analysis of bone marrow plasma cells, healthy adult donors, post-vaccination sampling
Key findings:
Limited presence of SARS-CoV-2-specific long-lived plasma cells in bone marrow after mRNA vaccination or hybrid immunity
Data source:
Bone marrow aspirates, hip joint replacement surgery samples
Limitations:
Small sample size, discrepancies in patient description, consideration of asymptomatic infections
Scientific relevance:
Provides evidence on the longevity of humoral immune response post-vaccination
Concise description:
Peer-reviewed evaluation of a study assessing the presence of SARS-CoV-2-specific long-lived plasma cells in the bone marrow following mRNA vaccination and hybrid immunity, highlighting methodology, key results, and points for revision.
Year:
2020
Region / city:
United States, multiple states
Theme:
SARS-CoV-2, Healthcare personnel, COVID-19
Document type:
Protocol
Organization / institution:
Centers for Disease Control and Prevention (CDC), Emerging Infections Program
Author:
CDC Division of Healthcare Quality Promotion
Target audience:
Healthcare personnel, public health professionals, researchers
Period of action:
2020
Date of approval:
July 17, 2020
Date of changes:
Not specified
Context description:
Protocol for tracking SARS-CoV-2 infections and assessing risks among healthcare personnel in the United States during the COVID-19 pandemic.
Year:
2020
Region / city:
United States
Topic:
Healthcare personnel, SARS-CoV-2, COVID-19
Document Type:
Protocol
Organization:
Centers for Disease Control and Prevention (CDC), Emerging Infections Program
Author:
Centers for Disease Control and Prevention (CDC)
Target Audience:
Healthcare personnel, public health officials, researchers
Period of Validity:
Ongoing
Approval Date:
April 22, 2020
Date of Changes:
Not specified
Year:
2012
Region / city:
United Kingdom
Topic:
Tattooing, Body Art, Health Risks, Epidemiology, Guidelines
Document type:
Literature Review
Organization / institution:
Health Protection Agency, Chartered Institute of Environmental Health, Tattoo and Piercing Industry Union
Author:
Dr. Victor Aiyedun
Target audience:
Health professionals, regulators, practitioners
Period of validity:
Not specified
Approval date:
Not specified
Date of last modification:
Not specified
Year:
2023-2024
Region / City:
Las Vegas
Subject:
Public Health, Epidemiology, Biostatistics
Document Type:
Academic Catalog
Institution:
University of Nevada, Las Vegas
Author:
UNLV Graduate College
Target Audience:
Graduate Students, Public Health PhD Applicants
Duration:
2023-2024
Approval Date:
N/A
Date of Changes:
N/A
Context:
This document is an academic catalog outlining the required courses and structure for the Doctor of Philosophy program in Public Health with a focus on Epidemiology and Biostatistics at the University of Nevada, Las Vegas.
Year:
2016
Region / city:
Switzerland
Topic:
Nutritional Epidemiology
Document type:
Research article
Institution:
Plos Medicine
Author:
Lachat C et al.
Target audience:
Researchers, public health professionals, epidemiologists
Period of validity:
Not applicable
Date of approval:
2016
Date of changes:
Not applicable
Year:
2023-2024
Region / City:
Las Vegas, NV
Subject:
Dual Degree Program, Biostatistics, Epidemiology
Document Type:
Academic Catalog
Institution:
University of Nevada, Las Vegas
Author:
Graduate College
Target Audience:
Students of the Master of Public Health and Doctor of Medicine programs
Effective Period:
2023-2024 academic year
Approval Date:
Not specified
Date of Changes:
Not specified
Year:
2025-2026
Note:
Region / City
Topic:
Public Health, Biostatistics, Epidemiology
Document Type:
Catalog
Institution:
UNLV Graduate College
Target Audience:
Graduate students in Public Health
Period of validity:
2025-2026 academic year
Year:
2022-2023
Region / City:
Las Vegas, NV
Topic:
Public Health, Biostatistics, Epidemiology
Document Type:
Curriculum Guide
Institution:
University of Nevada, Las Vegas
Author:
UNLV Graduate College
Target Audience:
Graduate students in Public Health
Period of validity:
2022-2023 academic year
Approval Date:
Not specified
Modification Date:
Not specified